Population-level interventions for the primary prevention of dementia: a complex evidence review

被引:12
作者
Walsh, Sebastian [1 ,6 ]
Wallace, Lindsay [1 ]
Kuhn, Isla [2 ]
Mytton, Oliver [3 ]
Lafortune, Louise [1 ]
Wills, Wendy [4 ]
Mukadam, Naaheed [5 ]
Brayne, Carol [1 ]
机构
[1] Univ Cambridge, Cambridge Publ Hlth, Cambridge CB2 0SR, England
[2] Univ Cambridge, Sch Clin Med, Med Sch Lib, Cambridge CB2 0SP, England
[3] UCL, Great Ormond St Inst Child Hlth, London WC1N 1EH, England
[4] Univ Hertfordshire, Ctr Res Publ Hlth & Community Care, Hatfield AL10 9AB, England
[5] UCL, Div Psychiat, London W1T 7BN, England
[6] Cambridge Publ Hlth, Forvie Site,Robinson Way, Cambridge CB2 0SR, England
关键词
RISK-FACTORS; PREVALENCE; DISEASE; SOCCER;
D O I
10.1016/j.eclinm.2024.102538
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dementia risk reduction is a global public health priority. Existing primary prevention approaches have favored individual-level interventions, with a research and policy gap for population-level interventions. We conducted a complex, multi-stage, evidence review to identify empirical evidence on population-level interventions for each of the modifiable risk factors identified by the Lancet Commission on dementia (2020). Through a comprehensive series of targeted searches, we identified 4604 articles, of which 135 met our inclusion criteria. We synthesized evidence from multiple sources, including existing non-communicable disease prevention frameworks, and graded the consistency and comprehensiveness of evidence. We derived a population-level intervention framework for dementia risk reduction, containing 26 high- and moderate-confidence policy recommendations, supported by relevant information on effect sizes, sources of evidence, contextual information, and implementation guidance. This review provides policymakers with the evidence they need, in a useable format, to address this critical public health policy gap.
引用
收藏
页数:22
相关论文
共 27 条
  • [11] Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
    Nichols, Emma
    Steinmetz, Jaimie D.
    Vollset, Stein Emil
    Fukutaki, Kai
    Chalek, Julian
    Abd-Allah, Foad
    Abdoli, Amir
    Abualhasan, Ahmed
    Abu-Gharbieh, Eman
    Akram, Tayyaba Tayyaba
    Al Hamad, Hanadi
    Alahdab, Fares
    Alanezi, Fahad Mashhour
    Alipour, Vahid
    Almustanyir, Sami
    Amu, Hubert
    Ansari, Iman
    Arabloo, Jalal
    Ashraf, Tahira
    Astell-Burt, Thomas
    Ayano, Getinet
    Ayuso-Mateos, Jose L.
    Baig, Atif Amin
    Barnett, Anthony
    Barrow, Amadou
    Baune, Bernhard T.
    Bejot, Yannick
    Bezabhe, Woldesellassie M. Mequanint
    Bezabih, Yihienew Mequanint
    Bhagavathula, Akshaya Srikanth
    Bhaskar, Sonu
    Bhattacharyya, Krittika
    Bijani, Ali
    Biswas, Atanu
    Bolla, Srinivasa Rao
    Boloor, Archith
    Brayne, Carol
    Brenner, Hermann
    Burkart, Katrin
    Burns, Richard A.
    Camera, Luis Alberto
    Cao, Chao
    Carvalho, Felix
    Castro-de-Araujo, Luis F. S.
    Catala-Lopez, Ferran
    Cerin, Ester
    Chavan, Prachi P.
    Cherbuin, Nicolas
    Chu, Dinh-Toi
    Costa, Vera Marisa
    [J]. LANCET PUBLIC HEALTH, 2022, 7 (02) : E105 - E125
  • [12] Making sense of the evidence in population health intervention research: building a dry stone wall
    Ogilvie, David
    Bauman, Adrian
    Foley, Louise
    Guell, Cornelia
    Humphreys, David
    Panter, Jenna
    [J]. BMJ GLOBAL HEALTH, 2020, 5 (12):
  • [13] Rose G., 2008, ROSES STRATEGY PREVE
  • [14] The mental health and wellbeing impact of a Community Wealth Building programme in England: a difference-in-differences study
    Rose, Tanith C.
    Daras, Konstantinos
    Manley, Julian
    Mckeown, Mick
    Halliday, Emma
    Goodwin, Tom Lloyd
    Hollingsworth, Bruce
    Barr, Ben
    [J]. LANCET PUBLIC HEALTH, 2023, 8 (06) : E403 - E410
  • [15] AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
    Shea, Beverley J.
    Reeves, Barnaby C.
    Wells, George
    Thuku, Micere
    Hamel, Candyce
    Moran, Julian
    Moher, David
    Tugwell, Peter
    Welch, Vivian
    Kristjansson, Elizabeth
    Henry, David A.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 358
  • [16] Neurodegenerative disease among male elite football (soccer) players in Sweden: a cohort study
    Ueda, Peter
    Pasternak, Bjorn
    Lim, Carl-Emil
    Neovius, Martin
    Kader, Manzur
    Forssblad, Magnus
    Ludvigsson, Jonas F.
    Svanstroem, Henrik
    [J]. LANCET PUBLIC HEALTH, 2023, 8 (04) : E256 - E265
  • [17] What is a population-level approach to prevention, and how could we apply it to dementia risk reduction?
    Walsh, S.
    Wallace, L.
    Mukadam, N.
    Mytton, O.
    Lafortune, L.
    Wills, W.
    Brayne, C.
    [J]. PUBLIC HEALTH, 2023, 225 : 22 - 27
  • [18] Are Population-Level Approaches to Dementia Risk Reduction Under-Researched? A Rapid Review of the Dementia Prevention Literature
    Walsh, Sebastian
    Wallace, L.
    Kuhn, I.
    Mytton, O.
    Lafortune, L.
    Wills, W.
    Mukadam, N.
    Brayne, C.
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2023, 11 (01): : 241 - 248
  • [19] What would a population-level approach to dementia risk reduction look like, and how would it work?
    Walsh, Sebastian
    Govia, Ishtar
    Peters, Ruth
    Richard, Edo
    Stephan, Blossom C. M.
    Wilson, Nikki-Anne
    Wallace, Lindsay
    Anstey, Kaarin J.
    Brayne, Carol
    [J]. ALZHEIMERS & DEMENTIA, 2023, 19 (07) : 3203 - 3209
  • [20] Walsh S, 2022, LANCET NEUROL, V21, P1151, DOI 10.1016/S1474-4422(22)00428-8